---
title: "Calidi Biotherapeutics (CLDI.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CLDI.US/norm.md"
symbol: "CLDI.US"
name: "Calidi Biotherapeutics"
parent: "https://longbridge.com/en/quote/CLDI.US.md"
datetime: "2026-03-17T21:30:48.779Z"
locales:
  - [en](https://longbridge.com/en/quote/CLDI.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CLDI.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CLDI.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/CLDI.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/CLDI.US/norm.md)


# Calidi Biotherapeutics (CLDI.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -2.21 | -1.99 | -2.21 | -3.22 | -7.75 |
| ROE | -997.19% | -525.22% | -470.65% | 374.63% | 183.49% |
| Revenue | - | - | - | - | - |
| Net income | -10.82M | -5.71M | -4.99M | -4.10M | -5.05M |
| Operating income | -5.05M | -5.66M | -5.06M | -4.03M | -5.23M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 14.03M | 9.35M | 15.06M | 14.18M | 6.66M |
| Leverage | 1.95 | 4.50 | 2.06 | 7.21 | -0.6794 |
| BVPS | 0.9804 | 0.5828 | 2.48 | 0.8160 | -11.11 |
| Turnover | - | - | - | - | - |
| Cash & STI | 10.38M | 5.28M | 10.56M | 9.59M | 1.90M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 2.86M | 3.26M | 3.43M | 3.80M | 4.22M |
| Net debt | -7.07M | -1.27M | -5.86M | -2.56M | 7.13M |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -4.24M | -4.88M | -7.13M | -5.42M | -4.95M |
| Investing CF | -27000.00 | -57000.00 | -7000.00 | -5000.00 | -6000.00 |
| Financing CF | 9.48M | -469000.00 | 8.11M | 13.11M | 6.05M |
| Free CF | -1.95M | -2.32M | -4.54M | -4.02M | -3.35M |
| OCF coverage | -983.29% | -1086.86% | -425.99% | -22595.83% | -20608.33% |
| Repaid & issued | - | - | - | 0.0000 | 600000.00 |
| CapEx | -27000.00 | -57000.00 | -7000.00 | -5000.00 | -6000.00 |